17/06/2026
Young people remain at the centre of the HIV response, yet many still face barriers to accessing prevention options that work for their lives and circumstances.
As conversations around Lenacapavir grow, we asked young people whether they had heard about this HIV prevention injection and whether they believe it could play a role in reducing new HIV infections among youth.
Their responses reflect a desire for prevention choices that are effective, convenient, and designed with young people in mind.
National Department of Health (South Africa) Wits RHI TB HIV Care Right 2 Care loveLife